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Allergic diseases such as atopic dermatitis (AD) 
and asthma are orchestrated and enhanced by 
CD4+ Th2 lymphocytes and the cytokines they 
produce, namely IL-4, IL-5, and IL-13. These 
type two cytokines drive elevated serum IgE and 
infiltration of Th2 cells, eosinophils, and baso-
phils, which have been observed in patients with 
asthma and AD (Venge et al., 1996; Sudowe 
et al., 2000; Walter et al., 2001; Nakajima and 
Takatsu, 2007). IL-4 and IL-13 mediate their 
responses  by  activating  JAK  kinases  and 
STAT6, a transcription factor responsible for 
activating many allergy-associated genes (Kato 
and Schleimer, 2007).
The suppressor of cytokine signaling (SOCS) 
family of proteins is a key controller of cytokine 
responses, which can down-regulate specific cyto-
kine signals and consequently modify the im-
mune response (Alexander, 2002; Croker et al., 
2008; Dimitriou et al., 2008). SOCS1 and SOCS3 
have been shown to influence the Th1/Th2 bal-
ance (Kubo and Inoue, 2006; Yoshimura et al., 
2007; Palmer and Restifo, 2009). In particular, 
SOCS3 expression correlates with the severity 
of asthma and AD, as well as serum IgE levels in 
patients with allergy (Seki et al., 2003). Although 
SOCS2 is expressed in activated CD4+ T cells and 
its expression can regulate IL-2 and IL-3 signals 
(Tannahill et al., 2005), no role for SOCS2 in 
CD4+ T cell differentiation has yet been defined.
In this paper, we demonstrate that activated 
SOCS2/  CD4+  T  cells  show  significantly 
higher IL-4, IL-5, and IL-13 production and 
Th2 differentiation and that they had elevated 
SOCS3- and IL-4–induced STAT6 but blunted 
IL-6–induced STAT3 phosphorylation. More-
over, SOCS2/ mice were highly susceptible 
to AD  with  a  marked  eosinophilic  infiltrate 
and, after helminth antigen challenge, produced 
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The incidence of allergy and asthma in developed countries is on the increase and this trend 
looks likely to continue. CD4+ T helper 2 (Th2) cells are major drivers of these diseases and 
their commitment is controlled by cytokines such as interleukin 4, which are in turn regu-
lated by the suppressor of cytokine signaling (SOCS) proteins. We report that SOCS2/ 
CD4+ T cells show markedly enhanced Th2 differentiation. SOCS2/ mice, as well as RAG-
1/ mice transferred with SOCS2/ CD4+ T cells, exhibit elevated type 2 responses after 
helminth antigen challenge. Moreover, in in vivo models of atopic dermatitis and allergen-
induced airway inflammation, SOCS2/ mice show significantly elevated IgE, eosinophilia, 
type 2 responses, and inflammatory pathology relative to wild-type mice. Finally, after  
T cell activation, markedly enhanced STAT6 and STAT5 phosphorylation is observed in 
SOCS2/ T cells, whereas STAT3 phosphorylation is blunted. Thus, we provide the first 
evidence that SOCS2 plays an important role in regulating Th2 cell expansion and develop-
ment of the type 2 allergic responses.
© 2011 Knosp et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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thymus, spleen, and LN of SOCS2/ 
and  WT  mice  showed  similar  fre-
quency and numbers of CD4+, CD8+, 
double-positive,  and  double-negative 
T cells (Fig. S1, A and B), suggesting 
that T cell development was nor-
mal. However, as other SOCS fam-
ily members have important roles   
in determining the cytokine responsiveness of different Th 
subsets (Palmer and Restifo, 2009), we examined the cyto-
kine profile of CD4+ T cells from SOCS2/ mice after 
TCR stimulation in vitro. IL-2 and IFN- secretion were 
similar in CD4+ T cells from SOCS2/ and WT mice but, 
surprisingly, IL-4, IL-5, IL-10, and IL-13 levels were mark-
edly higher in the absence of SOCS2 (Fig. 1 A). Moreover 
mRNA levels of these cytokines were also enhanced when 
examined by real-time PCR (Fig. S1 C). Importantly the level 
of  GATA-3  mRNA  was  significantly  higher  in  SOCS2/ 
CD4+ T cells (Fig. S1 C), suggesting spontaneous enhance-
ment of Th2 polarization. To explore this more closely, we 
sorted naive CD4+CD25CD44low T cells and drove de 
significantly more type 2 cytokines relative to WT animals. In 
addition, OVA-sensitized SOCS2/ mice had significantly 
increased airway resistance, specific IgE, and airway inflamma-
tion after OVA challenge. Our data suggest a novel role for 
SOCS2 in controlling CD4+ lineage commitment and type 2 
allergic responses.
RESULTS
SOCS2 deficiency is associated with enhanced IL-4, IL-5, 
and IL-13 secretion and Th2 differentiation both in vitro 
and in vivo
SOCS2/ mice present with gigantism but with no reported 
obvious immune defect (Metcalf et al., 2000). Phenotyping of 
Figure 1.  Increased secretion of Th2-
associated cytokines in SOCS2/ mice 
in vitro and in vivo. (A) CD4+CD25 sple-
nocytes purified from WT and SOCS2/ 
mice were cultured for 3 or 5 d with 2 µg/ml 
of plate-bound anti-CD3, 1 µg/ml of 
plate-bound anti-CD28, and 5 U/ml IL-2 in 
triplicate and cytokine production was 
evaluated by ELISA. Data are representative 
of at least three independent experiments. 
(B) Naive CD4+CD25CD44 splenocytes 
were cultured for 7 d under Th2 polariza-
tion conditions. Frequency of CD4+IL-4+ 
cells (Th2 cells) was evaluated at days 4 
and 7 by intracellular staining. Data are 
representative of three independent experi-
ments performed in triplicate. (C) SOCS2/ 
and WT mice (n = 5 per group) were i.p. 
injected with 10,000 S. mansoni eggs or 
PBS. 10 d later, splenocytes were restimu-
lated with anti-CD3 and anti-CD28 or SEA 
and cytokine production was measured by 
ELISA. (D and E) The footpads of WT and 
SOCS2/ mice (n = 5 per group; D) or 
RAG-1/ mice reconstituted with CD4+  
T cells sorted from WT (n = 4 per reconsti-
tuted group; E) or SOCS2/ mice (n = 7 
per reconstituted group; E) were injected 
with 5,000 S. mansoni eggs or PBS. 10 d 
later, the amount of Th2 cells in popliteal 
LNs was determinate by IL-4 intracellular 
staining (D) or T1/ST2 (IL-33 receptor) 
staining (E). Data are representative of at 
least three experiments and presented as 
the mean and SEM of each group. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001.JEM Vol. 208, No. 7 
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RAG-1/  recipients  and  challenged 
with S. mansoni eggs. 10 d after injec-
tion, the number of Th2 (CD4+ T1/
ST2+) cells in popliteal LN was signifi-
cantly (P < 0.05) higher in mice re-
constituted with SOCS2-deficient T cells 
when compared with those reconsti-
tuted with WT cells (Fig. 1 E), show-
ing a requirement for SOCS2 expression in CD4+ T cells in 
controlling in vivo differentiation of Th2 cells. These obser-
vations indicate that SOCS2 deficiency unexpectedly favors 
Th2 polarization in vitro and in vivo and, therefore, that 
SOCS2 is a key regulator of Th2 differentiation.
SOCS2/ mice are more susceptible to AD
Atopic disorders are driven by an elevated Th2 response; 
therefore, we used an in vivo model of AD, which was pre-
viously described by Li et al., (2006), to assess whether 
SOCS2/ mice are more susceptible to atopy. Mice were 
treated daily with an application of the vitamin D3 analogue 
calcipotriol  (MC903). Topical  application  of  MC903  trig-
gered an AD-like response—increase in skin thickness—in all 
mice, but SOCS2/ mice exhibited earlier onset and more 
severe disease (Fig. 2 A). Histological examination showed red 
scaly lesioned skin, accompanied by epidermal hyperplasia 
with dermal lymphocyte infiltration that was more abundant 
in SOCS2/ mice (Fig. 2 B). Furthermore, the dermal 
inflammation was associated with a marked eosinophilic 
infiltrate that was significantly exaggerated in the SOCS2/ 
mice (P < 0.05; Fig. 2 C). Finally, analysis of cytokine secretion 
in restimulated auricular LN and spleen cells showed en-
hanced IL-4, IL-5, and IL-13, but not IFN-, levels from 
MC903-treated SOCS2/ compared with treated WT ani-
mals (P < 0.05; Fig. 2 D). All together, the data demonstrates 
that SOCS2/ mice were more susceptible to AD in this 
model, confirming an inhibitory effect of SOCS2 on the al-
lergic response in vivo.
novo Th2 differentiation in vitro. As shown in Fig. 1 B and 
Fig. S1 D, in naive CD4+ cells the absence of SOCS2 re-
sulted in a significantly higher frequency of Th2 cells (CD4+ 
IL-4+ cells; P < 0.001), thus indicating that SOCS2 must 
control polarization toward the Th2 lineage.
Because parasitic helminth Schistosoma mansoni eggs in-
duce a potent Th2 response (Fallon and Mangan, 2007), we 
used  this  model  to  compare Th2  responses  in  vivo  in 
SOCS2/ mice relative to WT animals. SOCS2/ and 
WT  mice  were  injected  intraperitoneally  with  10,000   
S. mansoni eggs and, 10 d later, splenocytes were restimu-
lated  with  anti-CD3/CD28  or  with  schistosome  soluble 
egg antigen (SEA). Both approaches induced marked type 2 
responses  in WT  mice  relative  to  PBS-challenged  mice 
(Fig.  1  C). Moreover, there was significantly (P < 0.05) 
greater production of the type 2 cytokines IL-4, IL-5, and 
IL-13 by splenic T cells from egg-injected SOCS2/ mice 
relative to WT mice after both nonspecific and antigen-
specific TCR stimulation (Fig. 1 C). Interestingly, spleno-
cytes  from  egg-injected  SOCS2/  mice  also  produced 
significantly lower amounts of IL-17 compared with WT 
mice (Fig. 1 C). To specifically enumerate the in vivo ex-
pansion of Th2 cells, S. mansoni eggs were injected into the 
footpads of SOCS2/ and WT mice. After 10 d, the fre-
quency of Th2 (CD4+ IL-4+) cells in the popliteal LN was 
significantly higher (P < 0.001) in SOCS2/ mice than in 
WT animals (Fig. 1 D). To confirm that SOCS2 deficiency in 
CD4+ T cells was directly responsible for the observed Th2 bias, 
naive SOCS2/ or WT CD4+ T cells were transferred into 
Figure 2.  SOCS2/ mice develop more 
severe AD than WT mice. (A) Calcipotriol 
(MC903) or ethanol was applied daily to the 
right ear of WT and SOCS2/ mice (n = 6 per 
group) and ear thickness was measured daily. 
(B) Representative pictures of H&E-stained ear 
sections from WT and SOCS2/ mice at the 
end of study (bars, 150 µm). (C) Quantitation of 
ear eosinophil infiltrates from 10 sections ran-
domly selected out of one representative mouse 
per group. (D) Three mice per group were sacri-
ficed at day 5, and auricular draining LN and 
spleen cells were isolated and restimulated in 
triplicate for 48 h with anti-CD3 and anti-CD28. 
Secreted cytokines were then measured by 
ELISA. Data are representative of three indepen-
dent experiments and are presented as mean 
and SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001.1526 SOCS2 regulates Th2 responses | Knosp et al.
mice in response to methacholine chal-
lenge (Fig. 3 A). In comparison, OVA-
sensitized SOCS2/ mice had a striking 
dose-dependent increase in RL, relative 
to OVA-sensitized WT animals, that was 
statistically  significant  (P  <  0.01)  at 
higher methacholine doses (Fig. 3 A). 
Histological analysis of lungs of OVA-
sensitized mice showed more marked 
inflammation in SOCS2/ mice rela-
tive to WT, with peribronchial infil-
trating  eosinophils  and  goblet  cell 
hyperplasia (Fig. 3 B). Consistent with a 
greater allergen-specific type 2 response, 
OVA-sensitized  SOCS2/  mice  had 
significantly enhanced levels of both   
total IgE (P < 0.05) and OVA-specific 
IgE (P < 0.001) compared with OVA-
treated WT animals (Fig. 3 C). Fur-
thermore, cells from the lung-draining 
mediastinal LN from OVA-sensitized 
SOCS2/ mice had significantly (P < 
0.05) greater production of type 2, but not type 1, cytokines 
relative to allergen-sensitized WT animals (Fig. 3 D). Again, 
we observed a significant reduction (P < 0.05) in IL-17 pro-
duction  in  response  to  antigen  challenge  in  T  cells  from 
SOCS2/ mice (Fig. 3 D). To formally determine that the 
enhanced allergen-induced lung inflammation in SOCS2-
deficient mice (Fig. 3, A–D) was attributed to specific altera-
tions in CD4+ cell function, we generated SOCS2/xOT/II 
mice. RAG-1/ mice were reconstituted either with CD4+  
T cells from SOCS2/xOT/II or OT/II mice. Recipients 
were then sensitized and challenged as previously described 
SOCS2/ mice have increased susceptibility to allergic 
airway inflammation
Given the marked predisposition of SOCS2/ mice to AD, 
we investigated whether SOCS2 deficiency resulted in an in-
creased response to OVA-induced allergic airway inflammation. 
SOCS2/ and WT mice were OVA challenged systemically 
and by aerosol to evoke airway inflammation and airway   
hyper-responsiveness (AHR). In the absence of allergen chal-
lenge, AHR, determined by lung resistance (RL), was not 
induced in PBS-treated SOCS2/ mice, with these mice 
having RL values comparable to those of PBS-treated WT 
Figure 3.  Increased allergic lung inflamma-
tion in SOCS2/ mice. (A) Methacholine-
induced RL in PBS or OVA-sensitized SOCS2/ 
and WT mice (n = 7 mice per group). (B) Repre-
sentative image of lung sections from each 
group stained with periodic acid-Schiff stain 
(bars, 50 µm). (C) Levels of total and OVA- 
specific IgE in serum of mice from each group. 
(D) Cells from mediastinal LN were restimulated 
in triplicates with media or anti-CD3 and anti-
CD28 and cytokine secretion was measured by 
ELISA. (E and F) RAG-1/ mice were reconsti-
tuted with PBS as control or with sorted CD4+  
T cells isolated from OTII or SOCS2/ OTII mice. 
The number of mice per group of reconstituted 
RAG-1/ mice was between five and nine. The 
mice were then sensitized and challenged with 
OVA and methacholine-induced RL was mea-
sured (E). The cytokine concentrations in the 
lungs were measured after homogenization (F). 
Data are from three independent experiments 
and are presented as the mean and SEM per 
group. *, P < 0.05; **, P < 0.01; ***, P < 0.001.JEM Vol. 208, No. 7 
Article
1527
Moreover, IL-4 was 
the most potent in-
ducer of SOCS2, suggesting a possible role for SOCS2 in lim-
iting Th2 differentiation. Interestingly, TGF- induced no 
detectable  SOCS2  expression  and  IL-12  induced  limited 
amounts in CD4+ T cells (Fig. 4 A). SOCSs are known to in-
hibit STAT activation, and STATs, in turn, play a key role in 
the differentiation and commitment of helper T cell subsets. 
STAT6 is associated with Th2 development, whereas STAT4 
and STAT3 reciprocally control Th1 and Th17 development, 
respectively (O’Shea et al., 2011). To examine the mechanism 
of preferential Th2 differentiation in SOCS2/ mice, we 
investigated  the  profile  of  STAT  activation  in  T  cells. 
SOCS2/ CD4+ T cells displayed constitutive and signifi-
cantly  enhanced  STAT6  phosphorylation  compared  with 
WT CD4+ T cells (Fig. 4 B and Fig. S3 A), suggesting that the 
SOCS2-deficient CD4+ T cells are hyper-responsive to IL-4 in 
vivo. Moreover, IL-2–induced STAT5 activation is thought to 
promote early Th2 cell differentiation (Zhu et al., 2003; Cote-
Sierra et al., 2004; Paul and Zhu, 2010) and we found that   
IL-2–induced  STAT5  phosphorylation  is  enhanced  in 
SOCS2/ CD4+ T cells. (Fig. 4 C and Fig. S3 B). Impor-
tantly, IL-2-mediated STAT5 activation was shown to induce 
and maintain IL-4R expression (Liao et al., 2008). How-
ever,  we  found  that  IL-4R  expression  was  unchanged   
(Fig. S3 D). Finally, although IL-12–mediated STAT4 acti-
vation was unaffected by the absence of SOCS2 (Fig. 4 D),   
with OVA and AHR evaluated. RAG-1/ animals that re-
ceived the SOCS2/xOT/II cells had significantly higher 
RL responses than RAG-1/ mice reconstituted with OT/II 
CD4+ T cells (Fig. 3 E). Moreover, this was associated 
with enhanced peribronchial cell infiltration and goblet cell 
hyperplasia in recipients of CD4+ from SOCS2/xOT/II 
mice relative to cells from OT/II mice (Fig. S2 A) and in-
creased bronchoalveolar cell infiltration (Fig. S2 B). Recipi-
ents of CD4+ from SOCS2/xOT/II mice had significantly 
increased secretion of Th2-associated cytokines, lower IL-17, 
and unaffected IFN- both in the lungs (Fig. 3 F) and in BAL 
fluid  (Fig.  S2  C).  Collectively,  the  data  demonstrate  that 
SOCS2/ mice are more susceptible to OVA-induced air-
way inflammation and this can be a direct result of increased 
Th2 phenotype in SOCS2-deficient CD4+ T cells.
Enhanced STAT5 and STAT6 phosphorylation and SOCS1 
and SOCS3 expression after T cell activation in the absence 
of SOCS2
In the different allergic models used in this study, SOCS2/ 
mice consistently had enhanced IL-4, IL-5, and IL-13 and re-
duced IL-17 expression. It was important, therefore, to deter-
mine which cytokines involved in T helper cell polarization 
actually induced SOCS2 expression. Consequently, we next 
investigated which cytokine signals induced SOCS2 in purified 
WT CD4+ T cells. Both IL-4 and IL-6 strongly induced SOCS2 
with expression being clearly up-regulated after 48 h (Fig. 4 A).   
Figure 4.  SOCS2 deficiency results in 
constitutive STAT6 activation, enhanced 
IL-2–mediated STAT5 activation, and  
reduced IL-6–mediated STAT3 activation.  
(A) CD4+ splenocytes from WT mice were 
cultured with anti-CD3 and anti-CD28 in the 
presence of 20 ng/ml IL-4, 200 U/ml IL-6,  
20 ng/ml IL-12, or 5 ng/ml TGF- for the indi-
cated times. Cells were then lysed and immuno-
blotted for the expression of SOCS2 and 
-tubulin. (B) CD4+ splenocytes were cultured 
with anti-CD3 and anti-CD28 for 48 h.  
200 ng/ml IL-4 was then added to the culture 
for times indicated. Cell were lysed and immuno-
blotted for phospho-STAT6. (C) After 48 h and 
preactivation with anti-CD3, anti-CD28,  
5 ng/ml TGF-, and 5 U/ml IL-2, CD4+ spleno-
cytes were incubated for 2 h in serum-free 
media, restimulated with 100 U/ml IL-2 for 
the indicated times, and immunoblotted for 
phospho-STAT5. (D and E) CD4+ splenocytes 
were preactivated for 48 h with anti-CD3 and 
anti-CD28, rested 2 h in serum-free media, 
and restimulated with 50 ng/ml IL-12 (D) or 
50 U/ml IL-6 (E) for the indicated times, lysed, 
and immunoblotted for phospho-STAT4 (D) or 
phospho-STAT3 (E). Total STAT6, STAT5, STAT4, 
or STAT3 expression was also assessed. Right 
panels show densitometry of phospho-STAT 
relative to total STAT. Data are mean and  
SEM from triplicates. *, P < 0.05; **, P < 0.01; 
***, P < 0.001. The data are representative  
of three independent experiments.1528 SOCS2 regulates Th2 responses | Knosp et al.
this should be further investigated, together with the effect of 
SOCS2 deficiency on APC, eosinophils, and mast cells in 
particular. However, as RAG-1/ mice reconstituted with 
SOCS2-deficient CD4+ T cells developed enhanced pathol-
ogy compared with those reconstituted with WT (Fig. 1 E; 
and Fig. 3, E and F), these findings suggest that SOCS2 exerts 
an intrinsic inhibition on CD4+ T cells, which prevents po-
larization toward Th2 both in vitro and in vivo. Interestingly, 
and consistent with the normal IFN- production we observe, 
SOCS2/ mice mount a normal Th1 response to L. major 
infection (Bullen et al., 2003).
SOCS2 has primarily been studied in relation to the regu-
lation of growth hormone and cytokine signaling and has not 
previously been thought to influence T cell lineage commit-
ment. CD4+ T cell lineage maturation is governed by the ex-
pression  of  master  regulator  transcription  factors  that  drive 
differentiation, but recent evidence suggests that their expres-
sion is not as stable as initially thought; indeed, there are now 
many examples of plasticity in Th cell subsets (Murphy and 
Stockinger, 2010). T cell plasticity and lineage fate are also 
governed by the cytokines they encounter after antigen recog-
nition. Therefore it is plausible that the SOCS proteins might 
play a significant role in Th cell polarization. Indeed, constitu-
tive expression of SOCS3 during CD4+ T cell differentiation 
facilitates Th2 expansion (Seki et al., 2003; Ozaki et al., 2005), 
whereas selective deletion of SOCS3 in T cells facilitated en-
hanced  STAT3  activation  and  elevated  IL-17  production 
(Chen et al., 2006). Moreover, recent studies have shown that 
SOCS3 may play a role in controlling regulatory T cell re-
sponses because SOCS3-deficient T cells demonstrate a Th3-
like phenotype with increased TGF- and IL-10 and increased 
STAT3 activation (Kinjyo et al., 2006; Taleb et al., 2009).
In conclusion, therefore, we propose that SOCS2 inhibits 
Th2 development, and that the enhanced STAT5 and STAT6 
phosphorylation in the absence of SOCS2 favors Th2 polar-
ization. Finally, we have defined new functions for SOCS2 in 
the regulation of allergic inflammation and, potentially, CD4+  
T cell differentiation, providing new insights on how the in-
fluence of SOCS proteins on T cell plasticity may be exploited 
for the development of therapies for atopic disorders.
MATERIALS AND METHODS
Mice. All experiments used 12–16-wk-old sex- and age-matched C57BL/6 and 
SOCS2/ mice. SOCS2/ mice were a gift from D.J. Hilton (Royal Mel-
bourne Hospital, Victoria, Australia) and were generated on a C57BL/6 back-
ground as previously described (Metcalf et al., 2000). C57BL/6 mice were either 
purchased from Harlan Laboratories or were WT littermates. RAG-1/ and 
OT/II strain mice on a C57BL/6 background were purchased from The Jackson 
Laboratory. OT/II mice were subsequently crossed to SOCS2/ mice in house 
to generate SOCS2/xOT/II mice. Mice were housed under specific patho-
gen-free conditions. All animal experiments were performed in compliance with 
either the UK Home Office or the Irish Department of Health and Children reg-
ulations and approved either by the Queen’s University Ethical Review Com-
mittee or by the Trinity College Bioresources Ethical Review Board.
T cell culture, purification, and differentiation. All in vitro assays were 
performed by using between two and three mice per group. After extraction, 
splenocytes and lymphocytes were depleted of erythrocytes by lysis with 
ammonium chloride solution. Cells were cultured at 106/ml in complete   
we  observed  consistent  blunting  of  IL-6–induced  STAT3 
phosphorylation (Fig. 4 E and Fig. S3 C). Interestingly, SOCS2 
expression was induced after IL-6 and TGF- stimulation 
(Fig. S3 E) and, when stimulated under Th17 polarization con-
ditions, SOCS2-deficient T cells express less RORt (Fig. S3 F) 
and secrete less IL-17 (Fig. S3 G). These results are consistent 
with the decreased IL-17 levels observed in vivo (Fig. 1 C and 
Fig. 3 D), including in the CD4+ cell reconstitution experi-
ments (Fig. 3 F and Fig. S2 C), and they suggest that SOCS2 is 
required for normal Th17 differentiation. STAT5 is known 
to inhibit Th17 differentiation (Laurence et al., 2007; Yang   
et al., 2011) and, therefore, our data suggest that the reduced 
STAT3 activation and increased IL-2–mediated STAT5 phos-
phorylation in the SOCS2/ T cells primes Th2 development, 
probably at the expense of Th17.
Interestingly, SOCS3 is a strong inhibitor of STAT3 signal-
ing (Elliott and Johnston, 2004) and constitutive expression of 
SOCS3 in T cells was shown to favor Th2 polarization (Seki 
et al., 2003). Moreover, several studies suggest that SOCS2 can 
control the expression of both SOCS1 and SOCS3 (Tannahill 
et al., 2005; Piessevaux et al., 2006). We therefore hypothesized 
that SOCS1 and SOCS3 levels may be altered in SOCS2-
deficient T cells. When splenocytes from SOCS2/ mice 
were stimulated with anti-CD3/CD28 and IL-2 for periods of 
up to 24 h, we consistently observed significantly elevated 
SOCS1 and SOCS3 expression (Fig. S4 A). Interestingly, in WT 
cells, SOCS2 expression after T cell activation correlated with 
loss of detectable SOCS3 protein (Fig. S4 A). To assess whether 
SOCS3  levels  were  elevated  in  Th2  cells  from  SOCS2/ 
mice, we purified and cultured CD4+ T cells for 7 d under Th2 
conditions. Basal levels of SOCS3 were higher in SOCS2-
deficient T cells relative to controls (Fig. S4 B), with the differ-
ence between WT and SOCS2/ cells being amplified under 
polarizing conditions (Fig. S4 C). Finally, we also found that 
SOCS1 and SOCS3 mRNA levels are elevated in SOCS2-
deficient CD4+ T cells stimulated for 3 and 5 d with anti-CD3/
CD28 antibodies (Fig. S4 D). Because SOCS1 and SOCS3 are 
important regulators of Th differentiation (Palmer and Restifo, 
2009), the elevated SOCS3 expression in SOCS2/ CD4+  
T cells would be consistent with the observation that SOCS3 
blocks Th17 development by inhibiting IL-6 and IL-23 re-
sponses (Chen et al., 2006) while favoring Th2 differentiation 
(Seki et al., 2003). It is therefore plausible that the increased 
levels of SOCS1 and SOCS3 may also affect polarization toward 
other subsets, indirectly favoring Th2 differentiation.
DISCUSSION
Collectively,  our  findings  show  that  SOCS2/  mice  are 
predisposed to AD and allergic lung inflammation and devel-
oped enhanced type 2 immune responses to helminth anti-
gen. Because the SOCS2 mice are ubiquitous knockouts, 
other immune cells also lacking SOCS2 could contribute to 
this phenotype. Of note, we made the observation that the 
SOCS2-deficient B cells do not spontaneously class-switch 
toward IgE (unpublished data), which could have explained 
the predisposition of the SOCS2/ mice for atopy. Of course, JEM Vol. 208, No. 7 
Article
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of the right ear (20 µl/ear) as described previously (Li et al., 2006; Elentner 
et al., 2009). Ethanol (20 µl/ear) was applied as a vehicle control. Ear thick-
ness was monitored daily using digital calipers (Kroeplin). Spleens and au-
ricular draining LNs of the MC903 or vehicle-treated mice were extracted 
at day 5 and at the end of the study. The cells were restimulated with anti-
CD3 and anti-CD28 and the supernatants harvested after 48 h. MC903 or   
vehicle-treated ear samples were formalin fixed, embedded in paraffin, and 
stained with hematoxylin and eosin. 10 fields were randomly defined through-
out the tissue and counted blindly by two people using a graticule at 400×. The 
number of eosinophils per square millimeter of tissue was then calculated.
Experimental allergic airway inflammation. Mice were sensitized with 
OVA to induce allergic airway inflammation in a protocol optimized for 
mice on C57BL/6J strain background, as described previously (Fallon et al., 
2009). Mice were administered 50 µg OVA in alum (Thermo Fisher Scientific) 
i.p. on days 0 and 14 and subjected to airway exposure with 1% OVA in PBS 
for 20 min on days 27–31. 24 h after the last OVA aerosol challenge, lung 
function was analyzed by an invasive method where mice were tracheosto-
mized and ventilated using a whole-body plethysmography with a pneumo-
tachograph linked to a transducer (EMMS) to determine changes in RL in 
response to increasing doses of inhaled methacholine (10, 30, 60, and   
100 mg/ml; Sigma-Aldrich). Lungs from allergen-sensitized and challenged 
mice were taken and fixed in 10% formaldehyde-saline for histology (Mangan 
et al., 2007). Sections of lungs were stained with hematoxylin and eosin for 
assessment of lung inflammation and Periodic acid-Schiff stained for the 
enumeration of goblet cells and mucus production.
OT/II CD4+ cell transfer model of allergic airway inflammation. 
Spleen and LNs were harvested from OT/II and SOCS2/xOT/II mice. 
CD4+ T cells were enriched from single cell suspension by negative selection 
using the EasySep mouse CD4+ T cell enrichment kit (STEMCELL Technol-
ogies). Enriched CD4+ T cells were subsequently sorted to >99% purity with 
a MoFlo (Beckman Coulter) using anti-CD4 (BD) antibodies. A total of 1.5 × 
107 purified CD4+ cells isolated from OT/II or SOCS2/xOT/II mice were 
injected i.v. into RAG-1/ recipient mice. Control mice received PBS. 
RAG-1/ mice were administered 50 µg OVA adsorbed onto alum (Thermo 
Fisher Scientific) i.p. on days 1 and 8 and were subjected to airway exposure 
with 1% OVA aerosol in PBS for 20 min on days 9–13. 24 h after the last OVA 
aerosol challenge, lung function and immunological analysis was performed as 
described in the previous section. Lavage was performed and cytokines were 
detected in BAL fluid as in the previous section. Lungs were homogenized and 
cytokines determined (expressed as picogram of cytokine per milligram of lung 
protein) as previously described (Mangan et al., 2007).
Immunoblotting and immunoprecipitation. CD4+ cells were prestimu-
lated with anti-CD3 and anti-CD28 for 48 h before activation with rIL-4 
(R&D Systems), rIL-12 (PeproTech), or rIL-6 (PeproTech) as indicated. Cells 
lysates were analyzed by Western blotting as previously described (Tannahill et al., 
2005). Phosphorylated STAT proteins were detected using the following anti-
bodies: phospho-STAT6 (Imgenex), phospho-STAT3 (Abcam), and phospho-
STAT4 (Invitrogen). Blots were subsequently reprobed with total STAT6, 3, or 
4 (Santa Cruz Biotechnology, Inc.). To analyze SOCS2 and SOCS3 expression, 
total splenocytes from WT or SOCS2/ mice were prestimulated with anti-
CD3, anti-CD28, and rIL-2 (R&D Systems) as shown. Cell lysates were immuno-
blotted  with  antibodies  against  SOCS3  (IBL  International),  SOCS2  (Cell 
Signaling Technology), and -tubulin (Sigma-Aldrich). For SOCS3 analysis in 
CD4+ cells, equal amounts of total protein were immunoprecipitated with anti-
SOCS3 (IBL International) that had been precoupled to protein A Sepharose 
beads. SOCS3 protein was subsequently analyzed by Western blotting as previ-
ously described (Tannahill et al., 2005). Densitometry was performed using 
ImageJ software (National Institutes of Health).
Statistical analysis. Data were analyzed with Prism4 (GraphPad Software). 
Statistical differences were determined by two-tailed unpaired or paired Stu-
dent’s t test as appropriate.
RPMI medium. Cells were activated with 2 µg/ml (eBioscience) or 0.5 µg/ml 
(BD) of plate-bound anti-CD3 (145-2C11) and 1 µg/ml (eBioscience) or   
4 µg/ml (BD) of plate-bound anti-CD28 (37–51). CD4+ T cells were iso-
lated using positive or negative selection kits (Miltenyi Biotec). Naive 
CD4+CD25CD44low T cells were preenriched using CD4 negative selection 
kit and sorted to >99% purity with a FACSAria II (BD) using anti-CD4 
(BD), anti-CD25 (eBioscience), and anti-CD44 (BD) antibodies. Naive cells 
were polarized toward Th2 with 5 µg/ml of plate-bound anti-CD3 and   
5 µg/ml of plate-bound anti-CD28 in the presence of 20 ng/ml of recombi-
nant IL-4 (R&D Systems) and 20 µg/ml of blocking IFN- (R&D Systems) 
as  previously  described  (Watford  et  al.,  2010).  Th17  differentiation  was 
driven by stimulating CD4+CD25 T cells with 2 µg/ml of plate-bound 
anti-CD3 and 1 µg/ml of plate-bound anti-CD28 antibodies in the presence 
of 1 ng/ml of recombinant human (rh) TGF- (R&D Systems), 200 U/ml 
rhIL-6 (R&D Systems), and 10 µg/ml of blocking IL-4 and IFN- anti-
bodies (R&D Systems) in complete IMDM medium (Invitrogen).
Immunological analysis. For real-time PCR, mRNA was extracted with 
the RNeasy kit (QIAGEN) and converted as first-strand cDNA with the 
MMLV reverse transcription (Invitrogen). Each PCR was performed on an 
MX3000P qPCR machine (Agilent Technologies) from 50 ng cDNA using 
SYBR green technology (QIAGEN), and genes were amplified with the fol-
lowing primers (Invitrogen): IL-4 (forward, 5-ACAGGAGAAGGGACGC-
CAT-3; reverse, 5-GAAGCCCTACAGACGAGCTCA-3), IL-5 (forward, 
5-AGCACAGTGGTGAAAGAGACCTT-3;  reverse,  5-TTCAATGCA-
TAGCTGGTGATTT-3), IL-13 (forward, 5-AGACCAGACTCCCCTGT-
GCA-3;  reverse,  5-TGGGTCCTGTAGATGGCATTG-3),  GATA3 
(forward, 5-AGGCAAGATGAGAAAGAGTGCCTC-3; reverse, 5-CTC-
GACTTACATCCGAACCCGGTA-3),  RORt  (forward,  5-CCGCTGA-
GAGGGCTTCAC-3;  reverse,  5-TGCAGGAGTAGGCCACATTACA-3), 
SOCS1  (forward,  5-ACCTTCTTGGTGCGCGAC-3;  reverse,  5-AAGC-
CATCTTCACGCTGAGC-3), SOCS2 (forward, 5-GGTTGCCGGAGG-
AACAGTC-3;  reverse,  5-GAGCCTCTTTTAATTTCTCTTTGGC-3), 
and SOCS3 (forward, 5-CCTTCAGCTCCAAAAGCGAG-3; reverse, 
5-GCTCTCCTGCAGCTTGCG-3). Cytokine secretion in cell culture   
supernatants was analyzed by ELISA (BD or R&D Systems). Total and   
antigen-specific serum IgE were measured by ELISA, as described previously 
(Mangan et al., 2007).
Flow cytometry. Surface marker expression was assessed by flow cytometry 
using anti-CD3 (BD), anti-CD4 (BD), or anti-CD8 (eBioscience). For cyto-
kine staining, cells were restimulated in complete medium at 37°C for 4 h with 
50 ng/ml PMA (Sigma-Aldrich), 500 ng/ml ionomycin (Sigma-Aldrich), and 
GolgiPlug (BD) or for 6 h with 2.5 µg/ml Concanavalin A (Sigma-Aldrich) 
and 10 µg/ml Brefeldin A (Sigma-Aldrich). Cells were fixed and permeabilized 
using the Cytofix/Cytoperm kit (BD), followed by intracellular anti–IL-4, 
anti–IFN-, or anti–IL-17 (BD or eBioscience) staining. For phospho-STAT 
analysis, the cells were fixed after stimulation, permeabilized with the Perm III 
buffer (BD), and stained with antibodies specific for phospho-STAT5, phospho-
STAT3, and phospho-STAT6 according to the Phosflow (BD) instructions. 
Data were collected on a CyAn flow cytometer (Beckman Coulter) or on BD 
FACSCanto II (BD) and analyzed using FlowJo software (Tree Star).
Helminth egg injections. Eggs from S. mansoni–infected mice were ob-
tained as described previously (Smith et al., 2009). SEA at <1 endotoxin 
unit/mg (Chromogenic LAL; BioWhittaker) was prepared as described pre-
viously (Smith et al., 2009). Mice were given an i.p injection of either 10,000 
S. mansoni eggs or PBS. For the adoptive transfer experiments, RAG-1/  
mice were reconstituted with CD4+ sorted from WT or SOCS2/ mice be-
fore injection. In separate experiments, 5,000 S. mansoni eggs or PBS were 
injected into the footpad of mice to examine local cellular responses to SEA. 
Mice were culled and spleens or popliteal LNs removed 10 d after injection.
AD. Calcipotriol (MC903; Sigma-Aldrich) was resuspended in ethanol at 
50 µM. A total of 1 nM was applied daily to the outer and inner surfaces 1530 SOCS2 regulates Th2 responses | Knosp et al.
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